Skip to main content

Find Clinical Trials

Home
Conditions
Blasts 30 Percent or Less of Bone Marrow Nucleated Cells

Clinical trial condition

Blasts 30 Percent or Less of Bone Marrow Nucleated Cells

Explore clinical trials studying Blasts 30 Percent or Less of Bone Marrow Nucleated Cells. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Blasts 30 Percent or Less of Bone Marrow Nucleated Cells trial results

Completed

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT03358719

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +20 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details